IBRNvsIHE
iShares Neuroscience and Healthcare ETF against iShares U.S. Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IHE | |
|---|---|---|
| Expense ratio | 0.47% | 0.40% |
| Assets | $7931.50T | $1.7B |
| Net flow, 1 month | +$2M | +$186M |
| Net flow, 1 year | +$2M | +$763M |
| Return, YTD | +27.9% | +27.4% |
| Return, 1 year | +68.6% | +54.9% |
| Avg daily volume | 3K | 280K |
| Holdings | 54 | 38 |
| Listed | Aug 23, 2022 | Apr 30, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS